Tagged with distribution

Switzerland As the spotlight turns towards optimising supply and delivery chains in pharma logistics, Swiss Post has distinguished itself as one of the early movers in trialling autonomous drone logistics for commercial purposes. In March 2017, the company and its partner, Matternet, received clearance from the Swiss aviation authority to fly…

Switzerland Alexander Bauer, chairman and co-founder of 4PL Central Station, introduces his company’s unique logistics service offering, and the role of fourth party logistics in the future of the pharmaceutical industry. You founded 4PL Central Station here in Basel back in 2000, alongside your son Olivier, with the idea of providing…

India R.S. Subramanian, country manager and Sandeep Juneja, vice president – Sales and Marketing, DHL Express India, explain why the world’s leading express logistics company is a trusted and accountable service provider for life sciences customers in India, and also how they are maximizing business development opportunities by growing their presence…

Lithuania Marius Giedraitis, director and founder of Balux, explains the company’s commitment to shipping high-value temperature-sensitive pharmaceuticals with quality goals of 99.5 percent of deliveries without any deviation by 2019. Could you please introduce the main activities and operations of Balux to our international audience? “Our niche strategy helps us to…

Serbia Silvana Džudžević, managing director of Serbia’s leading pharma wholesale and distribution specialist, Farmalogist, introduces the evolution of the company’s operations to now include several complementary services, its numerous partnerships with international MNCs, and its utilization of digital solutions to cement the company as the partner of choice moving forward. Could…

Austria Christoph Wahl and Gerlad Weirowski of DHL Global Forwarding Austria discuss the significance of the Austrian affiliate being chosen as lead office for CEE and the company’s life sciences and logistics hub. They also tackle emerging trends in the pharma logistics segment. DHL’s Austrian affiliate has recently been made the…

Austria Eva Bano, CEO of BANO, an exciting west Austrian company, discusses the company’s modern revamp and expansion from natural therapies to pharmaceutical products. She also explains the importance of a strong online presence, the opening of a new production plant and the distribution services they offer for potential partners within…

Colombia Carlos and Esteban Arteaga, CEO and Line Manager at Medivelius, a company that distributes European dermocosmetic products of the highest quality in a price driven Colombian market, discuss how their loyalty to skin stores has engendered their success, while highlighting the importance of developing strong ties with dermatologists. Medivelius is…

Ukraine Aleksandr Iavorskyi, founder and president of Biocon, Ukraine’s leading third-party logistics (3PL) company in the pharmaceutical and healthcare areas, provides insights into Biocon’s impressive development and unique partnership approach as well as the life-changing home delivery services that the company introduced into the Ukrainian market. He also documents the main…

Austria Dr. Erwin Klein, CEO and co-founder of easypharm, a generics and OTC company founded by Austrians for Austria, provides an overview of his exciting entrepreneurial experience and the challenges associated with establishing a new pharmaceutical company in Austria as well as his expert view on the current healthcare system. He…

Colombia Francisco Ricaurte, Country Manager for global logistics provider UPS in Colombia, discusses the importance of the Colombian market for UPS’s regional business, while sharing insights on the company’s recently opened state-of-the-art healthcare facility.  Mr. Ricaurte, you have been working for UPS for 20 years, occupying the position of country manager…

Indonesia Christian Eberle, president director at APL, explains the challenges and opportunities within the Indonesian healthcare distribution arena as well as the company’s strategy to bring more high-quality medicines to patients over the next two years. After over two years as CEO of APL, could you provide us with an overview…